Weldon Steven W 4
4 · GT Biopharma, Inc. · Filed Dec 15, 2020
Insider Transaction Report
Form 4
Weldon Steven W
DirectorCFO
Transactions
- Sale
Common Stock
2020-12-11$0.26/sh−50,000$13,000→ 4,400,000 total - Sale
Common Stock
2020-12-14$0.28/sh−50,000$14,000→ 4,350,000 total - Sale
Common Stock
2020-12-14$0.29/sh−50,000$14,500→ 4,300,000 total - Sale
Common Stock
2020-12-15$0.30/sh−50,000$15,000→ 4,203,700 total - Sale
Common Stock
2020-12-15$0.32/sh−50,000$16,000→ 4,103,700 total - Sale
Common Stock
2020-12-11$0.25/sh−50,000$12,500→ 4,450,000 total - Sale
Common Stock
2020-12-14$0.29/sh−46,300$13,427→ 4,253,700 total - Sale
Common Stock
2020-12-15$0.30/sh−50,000$15,000→ 4,153,700 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.